학술논문
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized study
Document Type
Article
Author
Source
In Annals of Allergy, Asthma & Immunology May 2021 126(5):576-583
Subject
Language
ISSN
1081-1206